Abbott FreeStyle Libre Launches New Technology

The great thing about technology is that it is always getting better. Advancements that were once revolutionary become commonplace, and new developments further increase performance, convenience, and accuracy. Such is the case with the Abbott FreeStyle Libre, which dramatically improved the lives of people with diabetes by facilitating continuous glucose monitoring (CGM).

Abbott introduced the popular little white sensor worn on the arm years ago along with a handheld scanner that users need to swipe over the sensor to get readings. Now, Abbott is on the cusp of making that swipe a thing of the past with a more automated and easier way to get blood glucose readings.

In September 2020, Abbott Diabetes obtained international approval of its tiny  FreeStyle Libre 3 version outside the United States, with plans to bring it to the U.S. in the near future.

No More Scanning Required

Libre 3 has several advantages over existing models, the biggest being the elimination of the need to scan the sensor. For many people, that continued need to scan before obtaining a result meant the Libre 2 still didn’t provide the ideal level of protection for high and low glucose levels. This is particularly important overnight, when hypoglycemia can be even more dangerous since users are asleep and not actively monitoring or experiencing symptoms.

Additionally, the new sensor is much smaller and thinner than previous versions, with about the same thickness as two pennies.

The new device generates a real-time blood glucose reading every minute and displays the result on the compatible Android or iPhone mobile app. This continuous data stream comes with optional real-time alerts for high and low blood sugar levels, along with instant glucose results. As with earlier FreeStyle models, the Libre 3 still must warm up for one hour before providing data. 

Closed-Loop Technology On The Way

Abbott has signed multiple development agreements with partners that will allow its Libre monitor to work with future closed-loop technology, or Automated Insulin Delivery (AID) systems.

In June 2020, the FDA granted the Libre 2 a special iCGM designation, meaning it has the potential to work with other pieces of diabetes technology. The new Libre 3 will likely receive the full iCGM approval shortly after its launch in the U.S.

Learn More About How CGM Can Change The Way You Manage Diabetes

CGM is a tested, customizable transceiver device that helps those with diabetes stay in control of their condition and their life. As technology like the Libre 3 continues to develop, CGM will become even more easy-to-use and provide the information users need when they need it with minimal effort and inconvenience.

Whether you’ve been living with diabetes for years or if you’ve recently received a diagnosis, CGM may be an excellent glucose monitoring solution. Contact us today to see if you qualify for CGM and access our guide to continuous glucose monitoring.

CALL US TO QUALIFY NOW

If you are not insured, or have a high deductible health insurance plan, you can still purchase the Freestyle Libre Reader and Sensors at extremely competitive prices. Prices starting as low as $99 per month

*Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings when you suspect readings may be in accurate, or when you experience symptoms that may be due to high or low blood glucose.

Reference 1: Data on file. Abbott Diabetes Care. 2, FreeStyle Libre 14 day User’s Manual

Indications and Important Safety Information

FreeStyle Libre and FreeStyle Libre 14 day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing and detecting trends and tracking patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments in persons (age 18 and older) with diabetes. The systems are intended for single patient use and require a prescription.

CONTRAINDICATIONS: Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.

WARNINGS/LIMITATIONS: Do not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. The system does not have alarms unless the sensor is scanned, and the system contains small parts that may be dangerous if swallowed. The system is not approved for pregnant women, persons on dialysis, or critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one. Review all product information before use or contact Abbott Toll Free (855-632-8658) or visit www.freestylelibre.us for detailed indications for use and safety information.html. . FreeStyle, Libre, and related brand marks are trademarks of Abbott Diabetes Care Inc. in various jurisdictions. Other trademarks are the property of their respective owners. ©2018 Abbott. ADC-09691 vLO 10/18